Switzerland has a low mortality rate from cardiovascular diseases, but little is known regarding prevalence and management of cardiovascular risk factors (CV RFs: hypertension, hypercholesterolemia and diabetes) in the general population. In this study, we assessed 10-year trends in self-reported prevalence and management of cardiovascular risk factors in Switzerland. data from three national health interview surveys conducted between 1997 and 2007 in representative samples of the Swiss adult population (49,261 subjects overall). Self-reported CV RFs prevalence, treatment and control levels were computed. The sample was weighted to match the sex - and age distribution, geographical location and nationality of the entire adult population of ...
Background and Purpose : Identification of the population at risk of stroke remains the best approac...
QUESTIONS UNDER STUDY: High blood pressure, the single leading health risk factor worldwide, contrib...
BACKGROUND: There is little information regarding the prevalence and management of dyslipidaemia in ...
PURPOSE: to assess the trends of prevalence of self-reported cardiovascular risk factors (CV RFs: hy...
Purpose: to assess the trends of self-reported prevalence of cardiovascular risk factors (CV RFs: hy...
BACKGROUND: There are no time trends in prevalence, unawareness, treatment, and control of hypertens...
In Switzerland, health policies are decided at the local level, but little is known regarding their ...
BACKGROUND: There are no time trends in prevalence, unawareness, treatment, and control of hypertens...
<div><h3>Background</h3><p>There are no time trends in prevalence, unawareness, treatment, and contr...
Introduction To estimate the prevalence of and trends in diabetes according to sociodemographic indi...
Abstract Background In Switzerland, health policies are decided at the local level, but little is kn...
Background: There are no time trends in prevalence, unawareness, treatment, and control of hypertens...
We assessed 1) trends in prevalence, awareness, treatment and control rates of dyslipidaemia and ass...
Few studies assessed incidence and determinants of hypertension. We assessed the incidence and deter...
Objective: To assess the prevalence levels of awareness, treatment and control of hypertension and a...
Background and Purpose : Identification of the population at risk of stroke remains the best approac...
QUESTIONS UNDER STUDY: High blood pressure, the single leading health risk factor worldwide, contrib...
BACKGROUND: There is little information regarding the prevalence and management of dyslipidaemia in ...
PURPOSE: to assess the trends of prevalence of self-reported cardiovascular risk factors (CV RFs: hy...
Purpose: to assess the trends of self-reported prevalence of cardiovascular risk factors (CV RFs: hy...
BACKGROUND: There are no time trends in prevalence, unawareness, treatment, and control of hypertens...
In Switzerland, health policies are decided at the local level, but little is known regarding their ...
BACKGROUND: There are no time trends in prevalence, unawareness, treatment, and control of hypertens...
<div><h3>Background</h3><p>There are no time trends in prevalence, unawareness, treatment, and contr...
Introduction To estimate the prevalence of and trends in diabetes according to sociodemographic indi...
Abstract Background In Switzerland, health policies are decided at the local level, but little is kn...
Background: There are no time trends in prevalence, unawareness, treatment, and control of hypertens...
We assessed 1) trends in prevalence, awareness, treatment and control rates of dyslipidaemia and ass...
Few studies assessed incidence and determinants of hypertension. We assessed the incidence and deter...
Objective: To assess the prevalence levels of awareness, treatment and control of hypertension and a...
Background and Purpose : Identification of the population at risk of stroke remains the best approac...
QUESTIONS UNDER STUDY: High blood pressure, the single leading health risk factor worldwide, contrib...
BACKGROUND: There is little information regarding the prevalence and management of dyslipidaemia in ...